Basic MaterialsChemicals
  • Price (NOK)418.50
  • Today's Change1.20 / 0.29%
  • Shares traded309.32k
  • 1 Year change-6.58%
  • Beta--
Data delayed at least 15 minutes, as of Aug 09 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Yara International ASA is a Norway-based international company that produces, distributes, and sells nitrogen-based mineral fertilizers and related industrial products. The Company operates through six segments: Europe, Americas, Africa & Asia, Global Plants & Operational Excellence, Industrial Solutions, and Clean Ammonia. Yara Internationals products offering includes YaraVita GRAMITREL, a multi-nutrient product for a balanced supply of nutrients to grains, YaraBela OPTI-NS 27-0-0, an ammonium nitrate with calcium, magnesium and sulfur as well as YaraTera KRISTALON PURPLE, that is suitable for potted plants in need of relatively low pondus Hydrogenii (pH). The Company has 11 subsidiaries including Yara International Employment Co AG, Yara North America Inc, Yara Clean Ammonia AS and Fertilizer Holdings AS.

  • Revenue in NOK (TTM)211.44bn
  • Net income in NOK14.53bn
  • Incorporated2003
  • Employees17.80k
  • Location
    Yara International ASADrammensveien 131OSLO 0277NorwayNOR
  • Phone+47 24157000
  • Fax+47 24157001
  • Websitehttps://www.yara.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Clariant AG49.98bn3.53bn60.43bn11.25k17.,457.305.302.218.053.1929.1630.647.633.660.8446--0.3475179.3113.26-5.65151.891.081.39--
Arkema SA108.97bn10.61bn67.27bn20.20k6.410.92993.990.617414.2314.23145.6698.030.84915.986.52568,194.808.416.6310.458.0724.5121.789.917.981.3035.560.319727.6720.744.79325.3324.819.627.91
Oci NV86.80bn11.79bn74.23bn3.72k6.312.762.410.85535.625.6241.4012.860.917315.3111.652,351,919.0023.631.8337.312.5834.9420.6525.764.151.3416.480.4092--81.8827.08421.0527.71-19.49--
Chr Hansen Holding A/S11.74bn2.28bn80.04bn3.95k35.024.6424.096.8212.9813.1166.8097.890.37743.406.812,228,983.007.3310.128.4312.7355.9457.4019.4421.610.838411.860.358361.3511.072.57-14.211.5714.8320.14
Imcd NV40.52bn2.77bn83.28bn4.01k30.035.2122.442.064.904.9071.6328.,090,717.008.305.6411.717.8221.7820.286.844.651.0419.700.450744.4723.8014.9172.5523.2223.7224.12
Umicore SA250.49bn5.24bn88.68bn11.35k16.572.5510.060.3542.192.19104.4114.202.577.6311.341,848,767.005.424.899.728.125.856.512.111.840.859910.940.412735.6116.1518.16374.1927.877.673.83
Evonik Industries AG159.89bn8.62bn96.80bn33.15k11.250.95745.060.60541.861.8734.5221.840.72324.877.92487,668.203.993.354.974.0126.4728.765.525.130.800329.420.288979.0822.593.2752.970.00-1.540.3454
Brenntag SE156.79bn5.96bn103.29bn17.21k17.322.4410.990.65883.893.89102.2027.561.598.366.67915,705.506.215.519.317.6623.1422.243.903.520.980813.040.398141.7221.946.50-3.904.477.506.67
Akron PAO27.50bn9.37bn105.73bn11.21k10.386.779.273.841,562.541,562.544,595.302,395.290.73542.9921.09--25.348.4035.9812.1759.9047.3434.4615.831.10--0.448981.994.385.43-86.33-26.953.50-19.73
Yara International ASA211.44bn14.53bn106.60bn17.80k7.341.444.560.504257.0557.05830.07291.491.244.2310.3811,878,440.008.172.8111.523.5727.4126.576.603.500.68459.310.3434150.2943.367.93-35.02-9.93-12.0023.39
Akzo Nobel NV101.24bn6.12bn121.96bn36.10k19.822.2712.231.203.413.3856.5729.820.67753.603.77310,701.
Novozymes A/S20.75bn4.13bn131.12bn6.64k39.1210.6021.656.3211.0511.0555.5440.790.66212.424.892,513,907.0013.2015.3617.9320.1356.9557.0319.9321.410.755219.290.386446.706.701.1211.360.62170.39176.58
PhosAgro PAO67.63bn20.86bn153.46bn25.00k7.36--6.032.271,001.521,001.523,247.01------------16.47--21.0147.7545.8030.8418.21--47.45--91.1565.6317.50665.9916.713.5731.48
Data as of Aug 09 2022. Currency figures normalised to Yara International ASA's reporting currency: Norwegian Krone NOK

Institutional shareholders

20.49%Per cent of shares held by top holders
HolderShares% Held
Folketrygdfondetas of 31 Dec 202117.93m7.04%
Sprucegrove Investment Management Ltd.as of 31 Dec 20215.09m2.00%
DNB Asset Management ASas of 31 Dec 20214.84m1.90%
The Vanguard Group, Inc.as of 08 Jul 20224.30m1.69%
Polaris Capital Management LLCas of 31 Dec 20214.08m1.60%
BlackRock Fund Advisorsas of 07 Jul 20224.03m1.58%
Storebrand Asset Management ASas of 31 Dec 20213.82m1.50%
KLP Kapitalforvaltning ASas of 31 Dec 20213.31m1.30%
Alfred Berg Kapitalforvaltning ASas of 30 Jun 20222.49m0.98%
Fidelity Management & Research Co. LLCas of 31 May 20222.30m0.90%
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.